MILAN (Reuters) - Italian diagnostics group DiaSorin said on Saturday it had received an Emergency Use Authorisation (EUA) from the U.S. Food and Drug Administration for a serological test kit for COVID-19.
DiaSorin also said it had recently signed a contract with the Biomedical Advanced Research and Development Authority to obtain funding to make the test available in the United States.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!